- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04579536
Effectiveness of Using (Vanish XT) in Prevention of Occlusal Caries: a RCT
Effectiveness of Using a Light Curable Resin Modified Glass Ionmer Cement Varnish (Vanish XT) in Prevention of Occlusal Caries: a Randomized Controlled Clinical Trial
Despite the continuous effort to prevent and treat dental caries, it continues to be one of the most common chronic diseases in both children and adults. Prevention and minimally intervention treatment by early detection of the lesion are becoming the new philosophy in managing dental caries. The prevalence of pit and fissure caries was found to be 90% of all dental caries in permanent molars. Moreover, the risk of caries development is higher soon after the tooth had erupted.
The purpose of the current study is; to evaluate the effectiveness of a resin-modified glass ionmer cement (Vanish XT) varnish in the prevention of occlusal caries and compare it to a fluoride varnish in newly erupted first permanent molars.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
material and method: The sample will comprise of 84 bilateral pairs of newly erupted first permanent molars in children with age of 6-9 years.This sample will be randomly selected after patient's screening from pediatric dentistry clinics at King Abdul-Aziz University Dental Hospital, Jeddah, Saudi Arabia. Informed written consent will be obtained from the parents prior to sampling.
Healthy children with all four first permanent molar will be included in the study. Children must have at least one pair of contralateral newly erupted first permanent molars free from caries. Teeth with deep pits and fissures free of caries, restorations, sealants, fracture, hypoplasia, or cracks will be included in the study.
The children who met the inclusion criteria will be enrolled in the trial after a signed consent form is obtained. Pairs of maxillary or mandibular first molars will be included so that one side will be randomly assigned to study group and the contralateral side to control group.
Study group: This group will consist of 84 first permanent molars. These molars will be sealed using light curing resin-modified glass ionomer varnish (ClinproTM XT Vanish, 3M ESPE, Dental Products, St. Paul, MN, USA)
Control group: This group will consist of 84 first permanent molars. These molars will receive 5% Sodium Fluoride (NaF) with Tri-Calcium Phosphate topical varnish (Vanish White Varnish, 3M ESPE, Dental Products, St. Paul, MN, USA). These molars will serve as a control group.
The clinical examination will be assessing the caries lesions at baseline and 3,6, 12, and 18 months by the trained and calibrated dentists' according to ICDAS II criteria (International Caries Detection and Assessment System). Teeth with deep pits and fissures, which scored 0 will be included in this study.
In addition, once the clinical examination is done, bitewing radiographs will be taken for each child on the first visit to diagnose caries at the baseline.
A child structured questionnaire to be completed by interviewing the parents (adopted from WHO Oral Health Questionnaire for Children) concerning the dental history of the child and oral hygiene habits will be given at the baseline and at each recall visit.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
P.O Box 80209
-
Jeddah, P.O Box 80209, Saudi Arabia, 21589
- Recruiting
- King abulaziz University, Dental University Hospital
-
Contact:
- Alaa M Baik, BDS,MSc
- Phone Number: 23580 00966126402000
- Email: ambaik@kau.edu.sa
-
Principal Investigator:
- Alaa M Baik, BDS,MSc
-
Sub-Investigator:
- Najlaa M Alamoudi, BDS,MSc,DSc
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy children having no history of any systemic condition.
- Children must have all four first permanent molar.
- Children must have at least one pair of contralateral newly erupted first permanent molars free from caries.
- Teeth with deep pits and fissures (at high risk for caries).
- These molars should be free of caries, restorations, sealants, fracture, hypoplasia, or cracks.
- High caries risk children.
Exclusion Criteria:
- Children whom their parents refused to sign the consent form.
- Children older than 9 years old.
- Medically compromised children.
- Children having discolored grooves, restored, caries, or hypoplastic first permanent molars.
- Children having proximal caries in first permanent molars.
- Children whose antagonist teeth were extracted or not erupted.
- Children with a known acrylate allergy.
- Uncooperative children.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: TRIPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Study group
This is the study group; it will consist of 84 first permanent molars.
These molars will be sealed using light curing resin-modified glass ionomer varnish (ClinproTM XT Vanish, 3M ESPE, Dental Products, St. Paul, MN, USA).
reapplication will be done after 3,6, 12, and 18 months.
|
Light curing resin-modified glass ionomer varnish (ClinproTM XT Vanish, 3M ESPE, Dental Products, St. Paul, MN, USA) will be used to seal 84 first permanent molars at baseline, 3, 6, 12 and 18 months.
Other Names:
|
|
OTHER: Control group
This group will consist of 84 first permanent molars.
These molars will receive 5% Sodium Fluoride (NaF) with Tri-Calcium Phosphate topical varnish (Vanish White Varnish, 3M ESPE, Dental Products, St. Paul, MN, USA).
These molars will serve as a control group.
reapplication will be done after 3,6, 12, and 18 months.
|
5% Sodium Fluoride (NaF) with Tri-Calcium Phosphate topical varnish (Vanish White Varnish, 3M ESPE, Dental Products, St. Paul, MN, USA) will be used on 84 first permanent molars at baseline, 3, 6, 12 and 18 months.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
caries development
Time Frame: 3 months
|
To evaluate development of occlusal caries in newly erupted permanent first molars using the ICDAS after treating the surface with light curable RMGI varnish and compare it with contra-lateral teeth which received white varnish.
|
3 months
|
|
caries development
Time Frame: 6 months
|
To evaluate development of occlusal caries in newly erupted permanent first molars using the ICDAS after treating the surface with light curable RMGI varnish and compare it with contra-lateral teeth which received white varnish.
|
6 months
|
|
caries development
Time Frame: 12 months
|
To evaluate development of occlusal caries in newly erupted permanent first molars using the ICDAS after treating the surface with light curable RMGI varnish and compare it with contra-lateral teeth which received white varnish.
|
12 months
|
|
caries development
Time Frame: 18 months
|
To evaluate development of occlusal caries in newly erupted permanent first molars using the ICDAS after treating the surface with light curable RMGI varnish and compare it with contra-lateral teeth which received white varnish.
|
18 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Alaa Baik
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Caries Prevention
-
Roya mohamed Hamad ElmaghrbiShofu Inc.Not yet recruitingCaries Prevention
-
Cairo UniversityActive, not recruitingCaries PreventionEgypt
-
Sarah Emad Ali El-DinUnknownCaries PreventionEgypt
-
Colgate PalmoliveCompleted
-
Universidad Nacional Autonoma de MexicoRecruiting
-
Alexandria UniversityCompletedEarly Childhood Caries (ECC) | Dental Caries Prevention | Oral Bacterial Colonization | Pediatric Oral HealthEgypt
-
University of ChileCompletedCaries Prevention | Caries ReductionChile
-
Mansoura UniversityCompletedDental Caries | Education | PreventionEgypt
-
Cairo UniversityUnknown
-
Marmara UniversityCompletedFissure Sealant | Caries Prevention | Glass Ionomer Cement | Fluoride Concentration | Resin
Clinical Trials on Light curable resin modified glass ionomer varnish
-
Ain Shams UniversityOctober University for Modern Sciences and ArtsNot yet recruiting
-
King Abdulaziz UniversityUnknownDental Caries | Dental White SpotSaudi Arabia
-
Al-Azhar UniversityCompleted
-
University of Nebraska3MWithdrawn
-
King Abdulaziz UniversityActive, not recruitingWhite Spot Lesions | White Spot Lesions [Initial Caries] on Smooth Surface of Tooth | Enamel HypomineralizationSaudi Arabia
-
Universidad Autonoma de San Luis PotosíCompletedMolar Hypomineralization, IncisorMexico
-
Aga Khan University Hospital, PakistanCompletedOrthodontics | Malocclusion; Displaced or Missing Teeth | Bracket BondingPakistan
-
University of MichiganTerminatedQuality of Life | Cervical AbrasionUnited States
-
Mohamed zidanCairo UniversityUnknownWhite Spot Lesion of Tooth
-
Vilniaus Implantologijos Centro (VIC) KlinikaHarvard School of Dental MedicineCompletedDental CementsLithuania